GE HealthCare Technologies Inc. $GEHC Shares Acquired by Nippon Life Global Investors Americas Inc.

Nippon Life Global Investors Americas Inc. increased its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 6.3% during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 426,950 shares of the company’s stock after acquiring an additional 25,310 shares during the period. GE HealthCare Technologies makes up approximately 1.4% of Nippon Life Global Investors Americas Inc.’s holdings, making the stock its 26th largest holding. Nippon Life Global Investors Americas Inc. owned about 0.09% of GE HealthCare Technologies worth $32,064,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of GEHC. Allianz SE boosted its stake in shares of GE HealthCare Technologies by 165.2% in the second quarter. Allianz SE now owns 350 shares of the company’s stock valued at $26,000 after purchasing an additional 218 shares during the period. E Fund Management Hong Kong Co. Ltd. lifted its holdings in GE HealthCare Technologies by 130.7% in the 3rd quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock worth $26,000 after buying an additional 196 shares in the last quarter. Godsey & Gibb Inc. acquired a new position in GE HealthCare Technologies in the 3rd quarter worth $26,000. Gladwyn Financial Advisors Inc. purchased a new position in GE HealthCare Technologies in the 2nd quarter valued at about $34,000. Finally, Piscataqua Savings Bank grew its stake in shares of GE HealthCare Technologies by 173.4% during the third quarter. Piscataqua Savings Bank now owns 473 shares of the company’s stock valued at $36,000 after acquiring an additional 300 shares in the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Wall Street Analysts Forecast Growth

GEHC has been the topic of several recent analyst reports. Morgan Stanley boosted their price target on GE HealthCare Technologies from $74.00 to $80.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 30th. Citigroup upped their target price on GE HealthCare Technologies from $83.00 to $88.00 and gave the company a “neutral” rating in a research report on Thursday, December 11th. Evercore ISI restated an “outperform” rating and issued a $95.00 price target on shares of GE HealthCare Technologies in a research note on Monday, January 5th. Jefferies Financial Group upped their price target on shares of GE HealthCare Technologies from $95.00 to $105.00 and gave the company a “buy” rating in a report on Thursday, December 11th. Finally, UBS Group lowered shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and raised their price objective for the stock from $73.00 to $77.00 in a report on Thursday. Seven investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $89.83.

GE HealthCare Technologies Stock Performance

Shares of GEHC opened at $81.75 on Friday. The firm has a fifty day moving average of $81.29 and a 200-day moving average of $77.04. The company has a market cap of $37.24 billion, a price-to-earnings ratio of 16.89, a price-to-earnings-growth ratio of 3.18 and a beta of 1.08. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.95 and a current ratio of 1.18. GE HealthCare Technologies Inc. has a 1 year low of $57.65 and a 1 year high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Wednesday, October 29th. The company reported $1.07 earnings per share for the quarter, beating the consensus estimate of $1.05 by $0.02. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The firm had revenue of $5.14 billion for the quarter, compared to the consensus estimate of $5.07 billion. During the same period last year, the firm posted $1.14 EPS. GE HealthCare Technologies’s quarterly revenue was up 5.8% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. As a group, equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Friday, January 9th will be issued a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend is Friday, January 9th. GE HealthCare Technologies’s dividend payout ratio is 2.89%.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.